Department of Pathology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guang Zhou, China.
Department of Internal Medicine, Chicago Medical School, Chicago, USA.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241272527. doi: 10.1177/03946320241272527.
Given the implications of concurrent human papilloma viral infection (HPV) in the prognostic course and implications on therapeutic approached of patients with oral squamous cell carcinoma (OSCC), we seek to investigate the implications that P16 expression has on the clinical course and pathological appearance of patients with OSCC and concurrent infection.
Using S-P immunohistochemistry, we examined the expression of P16 and Ki67 in 460 patients with OSCC. We compared the expression of the protein between the tumor cells and normal epithelial mucosa within the same patient. The clinical and pathological characteristics (including gender, age, histological grade, lymph node metastasis, clinical stage, clinical recurrence, tumor diameter, Ki67 proliferation index) were analyzed by stratification statistically.
In total 460 cases of OSCC were identified and expression of P16 was significantly higher in the OSCC group compared to the normal mucosal epithelial group (X2 = 60.545, = .000). There also appear to be a gender predilection as the expression was higher in females compared to males (0.218 vs. 0.144, X2 = 3.921, = .048). Younger age also appears to be a predictive factor as those under 35 years old had higher expression of the protein compared to those over 35 years old (0.294 vs. 0.157, X2 = 4.230, = .040). P16 positivity showed a significant positive correlation with histologic grade (X2 = 4.114, = .043). In addition, the positive rate of P16 was higher in patients with ki67 over 85% (0.455 vs. 0.160, X2 = 6.667, = .023).
OSCC with HPV infection tends to occur more frequently in female patients and those under 35 years of age. HPV infection with expression of the P16 and ki67 protein may promote the proliferation and growth of OSCC at a higher frequency.
鉴于人乳头瘤病毒(HPV)感染对口腔鳞状细胞癌(OSCC)患者的预后和治疗方法的影响,我们旨在研究 P16 表达对 HPV 感染合并 OSCC 患者的临床病程和病理表现的影响。
采用 S-P 免疫组织化学法,检测 460 例 OSCC 患者的 P16 和 Ki67 表达情况。我们比较了同一患者肿瘤细胞与正常上皮黏膜的蛋白表达。通过分层统计分析,对蛋白表达与患者的临床和病理特征(包括性别、年龄、组织学分级、淋巴结转移、临床分期、临床复发、肿瘤直径、Ki67 增殖指数)进行了比较。
共检出 460 例 OSCC 病例,OSCC 组 P16 表达明显高于正常黏膜上皮组(X2=60.545,P=0.000)。此外,女性的表达似乎也存在性别倾向,高于男性(0.218比 0.144,X2=3.921,P=0.048)。年轻也是一个预测因素,因为 35 岁以下患者的蛋白表达高于 35 岁以上患者(0.294比 0.157,X2=4.230,P=0.040)。P16 阳性与组织学分级呈显著正相关(X2=4.114,P=0.043)。此外,P16 阳性率在 Ki67 超过 85%的患者中更高(0.455比 0.160,X2=6.667,P=0.023)。
HPV 感染合并 OSCC 更常发生于女性和 35 岁以下的患者。HPV 感染和 P16、Ki67 蛋白的表达可能会以更高的频率促进 OSCC 的增殖和生长。